Evidence map›Paper›PMID 37409272›Full record

ReviewFrontiers in medicine2023

Management of keratoconus: an updated review.

Rashmi Deshmukh, Zun Zheng Ong, Radhika Rampat, Jorge L Alió Del Barrio, Ankur Barua, Marcus Ang, Jodhbir S Mehta, Dalia G Said, Harminder S Dua, Renato Ambrósio and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 2 pooled it
29.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it, 129 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Trends in the Management of Keratoconus in Australia.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 5 countries.

Rashmi DeshmukhDepartment of Cornea and Refractive Surgery, LV Prasad Eye Institute, Hyderabad, India.
Zun Zheng OngDepartment of Ophthalmology, Queen's Medical Centre, Nottingham, United Kingdom.
Radhika RampatDepartment of Ophthalmology, Royal Free London NHS Foundation Trust, London, United Kingdom.
Jorge L Alió Del BarrioCornea, Cataract and Refractive Surgery Unit, Vissum (Miranza Group), Alicante, Spain.
Ankur BaruaBirmingham and Midland Eye Centre, Birmingham, United Kingdom.
Marcus AngSingapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore.
Jodhbir S MehtaSingapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore.
Dalia G SaidDepartment of Ophthalmology, Queen's Medical Centre, Nottingham, United Kingdom.
Harminder S DuaDepartment of Ophthalmology, Queen's Medical Centre, Nottingham, United Kingdom.
Renato AmbrósioDepartment of Cornea and Refractive Surgery, Instituto de Olhos Renato Ambrósio, Rio de Janeiro, Brazil.
Darren Shu Jeng TingBirmingham and Midland Eye Centre, Birmingham, United Kingdom.
Queen's Medical Centre · GBBirmingham and Midland Eye Centre · GBInstituto de Olhos de Goiânia · BRL V Prasad Eye Institute · INMiranza · ESRoyal Free London NHS Foundation Trust · GBSingapore Eye Research Institute · SGSingapore National Eye Center · SGUniversity of Birmingham · GBUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keratoconus is the most common corneal ectatic disorder. It is characterized by progressive corneal thinning with resultant irregular astigmatism and myopia. Its prevalence has been estimated at 1:375 to 1:2,000 people globally, with a considerably higher rate in the younger populations. Over the past two decades, there was a paradigm shift in the management of keratoconus. The treatment has expanded significantly from conservative management (e.g., spectacles and contact lenses wear) and penetrating keratoplasty to many other therapeutic and refractive modalities, including corneal cross-linking (with various protocols/techniques), combined CXL-keratorefractive surgeries, intracorneal ring segments, anterior lamellar keratoplasty, and more recently, Bowman's layer transplantation, stromal keratophakia, and stromal regeneration. Several recent large genome-wide association studies (GWAS) have identified important genetic mutations relevant to keratoconus, facilitating the development of potential gene therapy targeting keratoconus and halting the disease progression. In addition, attempts have been made to leverage the power of artificial intelligence-assisted algorithms in enabling earlier detection and progression prediction in keratoconus. In this review, we provide a comprehensive overview of the current and emerging treatment of keratoconus and propose a treatment algorithm for systematically guiding the management of this common clinical entity.

Indexed as

artificial intelligencecontact lenscorneacorneal cross-linkingcorneal transplantintracorneal ring segmentkeratoconusrefractive surgery

Identifiers

PMID37409272
PMCPMC10318194
OpenAlexW4381335827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.